S&P 500

5.277,51

0,80%

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
AMEX
Pro-Pharmaceuticals, (PRW)
Pro-Pharmaceuticals, (PRW) Notícias

PRW

Pro (PRW)

Pro-Pharmaceuticals,

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:AMEX:PRW

1 2 3 4 5 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
05/01/2009	20:00	Edgar (US Regulatory)	Current report filing (8-K)	AMEX:PRW	Pro-Pharmaceuticals,
31/12/2008	10:00	Business Wire	Pro-Pharmaceuticals Provides Year-End Update	AMEX:PRW	Pro-Pharmaceuticals,
20/11/2008	10:00	Business Wire	Pro-Pharmaceuticals Files Registration Statement for Rights Offering to Its Shareholders	AMEX:PRW	Pro-Pharmaceuticals,
19/11/2008	20:23	Edgar (US Regulatory)	Securities Registration Statement (S-1)	AMEX:PRW	Pro-Pharmaceuticals,
14/11/2008	10:00	Business Wire	Pro-Pharmaceuticals to Commence Rights Offering to Shareholders	AMEX:PRW	Pro-Pharmaceuticals,
13/11/2008	19:15	Business Wire	Pro-Pharmaceuticals Receives Delisting Notice from NYSE Alternext US	AMEX:PRW	Pro-Pharmaceuticals,
07/11/2008	10:30	Business Wire	Pro-Pharmaceuticals Reports Third Quarter Results	AMEX:PRW	Pro-Pharmaceuticals,
07/11/2008	10:17	Edgar (US Regulatory)	Quarterly Report (10-Q)	AMEX:PRW	Pro-Pharmaceuticals,
06/11/2008	10:00	Business Wire	Pro-Pharmaceuticals to Present Corporate Update at the Rodman & Renshaw Annual Global Investment Conference	AMEX:PRW	Pro-Pharmaceuticals,
06/10/2008	08:00	Business Wire	Pro-Pharmaceuticals' Pre-NDA Meeting Scheduled with FDA	AMEX:PRW	Pro-Pharmaceuticals,
23/09/2008	12:27	Edgar (US Regulatory)	Pro Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)	AMEX:PRW	Pro-Pharmaceuticals,
18/09/2008	08:00	Business Wire	Pro-Pharmaceuticals' Management Outlines Strategic Initiatives	AMEX:PRW	Pro-Pharmaceuticals,
28/08/2008	08:00	Business Wire	FDA Grants IND for Pro-Pharmaceuticals' DAVANAT(R) to Treat Breast Cancer Patient	AMEX:PRW	Pro-Pharmaceuticals,
08/08/2008	08:10	Edgar (US Regulatory)	Pro Pharmaceuticals Inc - Current report filing (8-K)	AMEX:PRW	Pro-Pharmaceuticals,
08/08/2008	08:05	Business Wire	Pro-Pharmaceuticals Reports Second Quarter Results	AMEX:PRW	Pro-Pharmaceuticals,
08/08/2008	07:55	Edgar (US Regulatory)	Pro Pharmaceuticals Inc - Quarterly Report (10-Q)	AMEX:PRW	Pro-Pharmaceuticals,
06/08/2008	08:00	Business Wire	Pro-Pharmaceuticals Granted Pre-IND Meeting for Anti-Hypoxia Drug	AMEX:PRW	Pro-Pharmaceuticals,
04/08/2008	08:00	Business Wire	Amex Accepts Pro-Pharmaceuticals Compliance Plan	AMEX:PRW	Pro-Pharmaceuticals,
15/07/2008	08:00	Business Wire	Pro-Pharmaceuticals Has Requested a Pre-IND Meeting with the U.S. Food and Drug Administration	AMEX:PRW	Pro-Pharmaceuticals,
11/07/2008	08:00	Business Wire	Pro-Pharmaceuticals' Senior Executives to Be Featured on PBS' "Wealth & Wisdom"	AMEX:PRW	Pro-Pharmaceuticals,
10/07/2008	08:00	Business Wire	Pro-Pharmaceuticals Appoints Noted Pioneer in Liver Diseases, Scott L. Friedman, M.D., to Scientific Advisory Board	AMEX:PRW	Pro-Pharmaceuticals,
09/07/2008	08:00	Business Wire	Pro-Pharmaceuticals and Sanghyon Chemical Ink Historic Agency Agreement	AMEX:PRW	Pro-Pharmaceuticals,
25/06/2008	08:00	Business Wire	Pro-Pharmaceuticals' Executives Contribute to Definitive Book on Galectins	AMEX:PRW	Pro-Pharmaceuticals,
20/06/2008	10:20	Edgar (US Regulatory)	Pro Pharmaceuticals Inc - Prospectus filed pursuant to Rule 424(b)(3) (424B3)	AMEX:PRW	Pro-Pharmaceuticals,
20/06/2008	07:00	Edgar (US Regulatory)	Pro Pharmaceuticals Inc - Notice of Effectiveness (EFFECT)	AMEX:PRW	Pro-Pharmaceuticals,
10/06/2008	08:02	Edgar (US Regulatory)	Pro Pharmaceuticals Inc - Withdrawal of Registration Statement (RW)	AMEX:PRW	Pro-Pharmaceuticals,
29/05/2008	10:06	Business Wire	Pro-Pharmaceuticals, Inc. Retains the Investor Relations Group	AMEX:PRW	Pro-Pharmaceuticals,
21/05/2008	07:00	Business Wire	Pro-Pharmaceuticals Issues Letter to Shareholders	AMEX:PRW	Pro-Pharmaceuticals,
20/05/2008	08:30	Business Wire	Pro-Pharmaceuticals Announces Submission of Drug Master File for DAVANAT(R) to FDA	AMEX:PRW	Pro-Pharmaceuticals,
20/05/2008	07:30	Business Wire	Pro-Pharmaceuticals Receives Amex Non-Compliance Notice	AMEX:PRW	Pro-Pharmaceuticals,